Medicinal Genomics
Beverly, US · Founded 2009 · Delaware corporation · 1 known investors
Cannabis genomics company developing testing technologies to help growers, dispensaries, and labs ensure safe, quality cannabis.
Founders & leadership
Medicinal Genomics was founded in 2009 by Kevin J. McKernan.
KJ
Kevin J. McKernanFounder
PC
Patrick CostelloExecutive
BL
Brendan L. McKernanExecutive
RB
R. Brian McKernanChief Executive Officer
Board
PC
Philip ChapmanBoard director
MH
Mark H DeBloisBoard director
RU
CM
Charles M FarkasBoard director
RM
Richard McKernanBoard director
EG
Emery G. OlcottBoard director
JJ
John J. AltorelliBoard director
SM
Stephen M. McLeanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 4 rounds · 2014–2020
▶$2.7MraisedApr 2021 · 65 investors · BiotechnologyRule 506(b)
▶$2.7MraisedApr 2021 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick CostelloExecutive Officer
- Charles M FarkasDirector
- Richard McKernanDirector
- Philip ChapmanDirector
- Mark H DeBloisDirector
- Brendan L McKernanExecutive Officer, Director
- Richard UptonDirector
- Kevin J. McKernanExecutive Officer
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2017 · 43 investors · BiotechnologyRule 506(b)
▶$5MraisedNov 2017 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Philip ChapmanDirector
- Charles M. FarkasDirector
- Mark H. DeBloisDirector
- Richard UptonDirector
- Brendan L. McKernanExecutive Officer, Director
- Patrick CostelloExecutive Officer
- Kevin J. McKernanExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedJun 2015 · 3 investors · BiotechnologyRule 506(b)
▶$7.5MraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Emery G. OlcottDirector
- Patrick B. CostelloExecutive Officer
- John J. AltorelliDirector
- Stephen M. McLeanDirector
- Philip ChapmanDirector
- Brendan L. McKernanExecutive Officer, Director
- R. Brian McKernanExecutive Officer, Director
- Richard UptonDirector
- Amount sold
- $7.5M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MraisedJun 2014 · 44 investors · BiotechnologyRule 506(b)
▶$6.3MraisedJun 2014 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard T. McKernanDirector
- Patrick B. CostelloExecutive Officer
- R. Brian McKernanExecutive Officer, Director
- Philip ChapmanDirector
- Richard UptonDirector
- Emery G. OlcottDirector
- John J. AltorelliDirector
- Stephen M. McLeanDirector
- Brendan L. McKernanExecutive Officer, Director
- Amount sold
- $6.3M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Medicinal Genomics do?
- Cannabis genomics company developing testing technologies to help growers, dispensaries, and labs ensure safe, quality cannabis.
- Who founded Medicinal Genomics?
- Medicinal Genomics was founded by Kevin J. McKernan in 2009.
- Who are Medicinal Genomics's investors?
- Medicinal Genomics's investors include Harbor Light Capital Partners.
- How much funding has Medicinal Genomics raised?
- Medicinal Genomics has disclosed $21.5M raised across 4 rounds.
- Where is Medicinal Genomics headquartered?
- Medicinal Genomics is headquartered in Beverly, US.